How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients
In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure, set off […]
Pharmaceutical industry
AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector
AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the chemical, pharmaceutical, […]
New update for ICH Q2 (R2) Analytical process validation guidance
As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2 (R2) Guideline […]
AMSbiopharma and LEF announce strategic partnership to expand service offering
AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal and part […]
AMSBIOPHARMA INTRODUCES AN IMPORTANT ADVANCE FOR THE ANALYSIS OF NITROSAMINES IN DIFFERENT ACTIVE PHARMACEUTICAL INGREDIENTS OF VITAMIN B12
AMSbiopharma, our specialized line of analytical solutions for the quality control of pharmaceutical products, announces the launch of a service […]